| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0046-8177(87)80330-1 |
| P698 | PubMed publication ID | 3804319 |
| P50 | author | Jacek J. Hawiger | Q88341029 |
| P2860 | cites work | gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors | Q24301146 |
| Fibrinogen and fibrin | Q28267332 | ||
| Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
| Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease | Q33332381 | ||
| The bleeding time as a screening test for evaluation of platelet function | Q33464411 | ||
| Exposure of platelet fibrinogen receptors by ADP and epinephrine | Q33473239 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| ROLE OF PLATELET FIBRINOGEN IN THE REACTIONS OF PLATELETS TO THROMBIN. | Q34078944 | ||
| Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments | Q34480048 | ||
| Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis | Q34507395 | ||
| Plasmin inhibition of platelet function and of arachidonic acid metabolism | Q34530356 | ||
| Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib | Q34562071 | ||
| Interaction of von Willebrand factor with human platelets in the plasma milieu | Q34602783 | ||
| Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets | Q34604791 | ||
| Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion | Q34619713 | ||
| Role of thrombospondin in platelet aggregation | Q34619920 | ||
| A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin | Q34621106 | ||
| Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation | Q35047906 | ||
| Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells | Q35051655 | ||
| Studies on the structural abnormality of fibrinogen Paris I | Q35199051 | ||
| Subcellular localization and secretion of factor V from human platelets | Q35469007 | ||
| Factor XIII in human plasma and platelets | Q35570072 | ||
| The measurement of thrombin in clotting blood by radioimmunoassay | Q35905215 | ||
| Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. | Q36212080 | ||
| Activation of factor IX bound to cultured bovine aortic endothelial cells | Q36254648 | ||
| Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets | Q36314768 | ||
| Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells | Q36349437 | ||
| Cloning and characterization of two cDNAs coding for human von Willebrand factor. | Q36413864 | ||
| Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method | Q36487544 | ||
| Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets | Q36983829 | ||
| Complex formation of platelet thrombospondin with fibrinogen | Q36985923 | ||
| Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium | Q36992682 | ||
| Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets | Q37037311 | ||
| Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency * | Q37038122 | ||
| Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII | Q37042626 | ||
| ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets | Q37562150 | ||
| Variants of the cell recognition site of fibronectin that retain attachment-promoting activity | Q37569976 | ||
| Binding of factors IX and IXa to cultured vascular endothelial cells | Q37616676 | ||
| An endothelial cell-dependent pathway of coagulation | Q37685042 | ||
| A monoclonal antibody against human thrombospondin inhibits platelet aggregation | Q37688937 | ||
| Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin | Q37690541 | ||
| Cross-linking of plasma and cellular fibronectin by plasma transglutaminase | Q39279555 | ||
| Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma | Q39791854 | ||
| The primary inhibitor of plasmin in human plasma | Q39798582 | ||
| Interaction between vitamin K-dependent protein S and the complement protein, C4b-binding protein. A link between coagulation and the complement system | Q40117539 | ||
| Acquired antibody to factor XI in a patient with congenital factor XI deficiency | Q40681162 | ||
| Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay | Q40683743 | ||
| Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium | Q40713235 | ||
| Anti-platelet action of intravenous infusion of prostacyclin in man | Q40939305 | ||
| A double blind placebo controlled crossover study of prostacyclin in man | Q41121326 | ||
| Adhesion of platelets to laminin in the absence of activation | Q41473926 | ||
| Inhibition of von Willebrand factor–platelet interaction by fibrinogen | Q41559907 | ||
| Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen | Q42265998 | ||
| Thrombin-induced platelet aggregation is mediated by a platelet plasma membrane-bound lectin | Q43861672 | ||
| Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. | Q45855991 | ||
| Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization | Q48377892 | ||
| Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen? | Q55061969 | ||
| Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets | Q59054137 | ||
| Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal | Q59065336 | ||
| Thrombospondin is the endogenous lectin of human platelets | Q59084076 | ||
| Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I) | Q59086900 | ||
| Adenosine diphosphate induces binding of von Willebrand factor to human platelets | Q59095973 | ||
| Platelet adhesion to type III collagen : involvement of a sequence of nine aminoacids from alpha 1 (III) CB peptide | Q66968625 | ||
| Factor XI deficiency: detection and management during urological surgery | Q67330050 | ||
| The amino-terminal sequence of streptokinase and its functional implications in plasminogen activation | Q67444800 | ||
| Equilibrium binding of thrombin to platelets | Q67861772 | ||
| Streptokinase | Q68236982 | ||
| Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells | Q70056923 | ||
| Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chain | Q70211601 | ||
| Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits | Q70281110 | ||
| Binding of coagulation factors IX and X to the endothelial cell surface | Q70429831 | ||
| Tissue plasminogen activator: chemical and physiological aspects | Q70468659 | ||
| Interaction of specific platelet membrane proteins with collagen: evidence from chemical cross-linking | Q70581513 | ||
| Antibodies against a 23Kd heparin binding fragment of thrombospondin inhibit platelet aggregation | Q70667344 | ||
| γ-γ Cross-linking sites in human and bovine fibrin | Q70735278 | ||
| Von Willebrand factor has more than one binding site for platelets | Q71011365 | ||
| Influence of alpha 2-plasmin inhibitor on adsorption of plasminogen to fibrin | Q71417822 | ||
| Evidence that a collagen-derived nonapeptide is a specific inhibitor of platelet-collagen interaction | Q71429696 | ||
| Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia | Q71787277 | ||
| Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets | Q72082906 | ||
| Heredity and Coagulation Studies in Ten Families with Factor XI (Plasma Thromboplastin Antecedent) Deficiency | Q72630584 | ||
| Preparation and application of a photoreactive thrombin analog: binding to human platelets | Q72908042 | ||
| Platelet aggregation: Part II Some results from a new method of study | Q79818747 | ||
| ??? | Q64800736 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 111-122 | |
| P577 | publication date | 1987-02-01 | |
| P1433 | published in | Human Pathology | Q15756731 |
| P1476 | title | Formation and regulation of platelet and fibrin hemostatic plug | |
| P478 | volume | 18 |
| Q89396759 | A Prospective, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Fibrin Sealant Grifols as an Adjunct to Hemostasis as Compared to Cellulose Sheets in Hepatic Surgery Resections |
| Q77764375 | A novel surface-active peptide derivative exhibits in vitro inhibition of platelet aggregation |
| Q44720874 | An hypothesis on the consolidation and PGE1-induced deconsolidation of a platelet plug |
| Q36037022 | Biocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery |
| Q39143549 | Drug delivery using platelet cancer cell interaction. |
| Q35224506 | Dynamics in Thrombus Formation |
| Q42954245 | Effects of platelets on the protein expression in aortic segments: A proteomic approach |
| Q45182160 | Endoscopic closure of fetal membrane defects: comparing iatrogenic versus spontaneous rupture cases |
| Q35991236 | Factor v leiden and inflammation |
| Q36165666 | High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor |
| Q30438797 | High-speed platelet adhesion under conditions of rapid flow |
| Q41831369 | In Vitro and Ex Vivo Approaches to Evaluate Next-Generation Tobacco and Non-Tobacco Products on Human Blood Platelets |
| Q73745033 | Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage |
| Q54091449 | Induction of patching and its reversal on surface-activated human platelets. |
| Q40509331 | Interaction of dietary factors with oral anticoagulants: review and applications |
| Q69828706 | Isolation and characterization of a platelet surface collagen binding complex related to VLA-2 |
| Q46103399 | Maintenance of patency after vascular trauma by topical irrigation with a peptide homologous to the carboxy-terminus of the fibrinogen gamma chain |
| Q43842966 | New developments of antiplatelet drugs |
| Q73295821 | Novel Antithrombotic Strategies for the Treatment of Coronary Artery Thrombosis: A Critical Appraisal |
| Q34001532 | Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease |
| Q44590003 | Physical stability of liposomes bearing hemostatic activity. |
| Q42912264 | Platelet Anti-Aggregation Activities of Compounds from Cinnamomum cassia |
| Q73378426 | Platelet activation and its role in thrombin generation in platelet-induced thrombin generation time |
| Q47777118 | Platelet receptors for collagens |
| Q36505721 | PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage. |
| Q33701225 | Predictors of the success and failure of emergency pelvic artery embolisation for primary postpartum haemorrhage: a 12-year review |
| Q93113209 | Prevalence of Low Platelet Count and Identification of Associating Determinants and Genetic Polymorphism in Healthy Individuals of Upper Assam, India |
| Q77949128 | Prostaglandin E1-induced deconsolidation of thrombin-activated platelet aggregates I: ultrastructure-computer image analysis |
| Q36609428 | Resveratrol preserves the function of human platelets stored for transfusion |
| Q38215920 | Role of platelet inhibitor therapy in myocardial infarction |
| Q41203316 | The bleeding time: its potential utility among patients receiving thrombolytic therapy |
| Q30886800 | The effects of polysulfonate derivative (GL 2021) on coagulation in vitro and thrombosis in vivo |
| Q36220658 | The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen |
| Q33497019 | The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding |
| Q40925433 | Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies |
Search more.